bosentan anhydrous and Cruveilhier-Baumgarten Syndrome
bosentan anhydrous has been researched along with Cruveilhier-Baumgarten Syndrome in 31 studies
Research
Studies (31)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 2 (6.45) | 18.2507 |
| 2000's | 21 (67.74) | 29.6817 |
| 2010's | 8 (25.81) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Güllülü, S; Sağ, S; Yeşilbursa, D | 1 |
| Hatano, M; Imamura, T; Kinugawa, K; Komuro, I; Maki, H; Muraoka, H; Yao, A | 1 |
| Chuang, CL; Hsin, IF; Hsu, SJ; Huang, HC; Lee, FY; Lee, JY; Lee, SD; Lin, HC; Lin, TY; Wang, SS | 1 |
| Li, D; Matuschak, GM; Nayak, RP | 1 |
| Hayashida, A; Hino, T; Kawamoto, T; Neishi, Y; Obase, K; Okahashi, N; Okura, H; Wada, N; Watanabe, N; Yoshida, K | 1 |
| Csete, M; Heffron, T; Knowles, D; Lawrence, EC; Tapper, EB | 1 |
| Cavasin, MA; Chapo, J; Peng, Y; Pitts, K; Plato, CF; Sandoval, J; Semus, H | 1 |
| Eriksson, C; Gustavsson, A; Kronvall, T; Tysk, C | 1 |
| Andrews, JC; Kamath, PS; Krowka, MJ; Swanson, KL; Talwalkar, JA | 1 |
| Aizawa, Y; Ito, E; Maie, K; Ohno, Y; Sato, A; Tanabe, Y; Yoshida, T | 1 |
| Berrevoet, F; Colle, I; De Pauw, M; Geerts, A; Raevens, S; Reyntjens, K; Rogiers, X; Troisi, RI; Van Vlierberghe, H; Verhelst, X | 1 |
| Halank, M; Hoeffken, G; Miehlke, S; Schmeisser, A; Schulze, M; Strasser, RH | 1 |
| Bramhall, S; Clift, PF; Isaac, JL; Townend, JN | 1 |
| Alber, H; Colleselli, D; Kähler, CM; Molnar, C; Vogel, W | 1 |
| Graziadei, IW; Hinterhuber, L; Jaschke, W; Kähler, CM; Vogel, W | 1 |
| Gerbes, AL; Gülberg, V; Kuntzen, C | 1 |
| Halank, M; Hoeffken, G; Hoeper, MM; Marx, C; Niedermeyer, J; Schauer, J; Seyfarth, HJ; Winkler, J | 1 |
| Halank, M; Hoeffken, G; Kolditz, M; Miehlke, S | 1 |
| Halank, M; Hoeffken, G; Kolditz, M; Miehlke, S; Schiemanck, S; Schmeisser, A | 1 |
| Stähler, G; von Hunnius, P | 1 |
| Eller, P; Fuschelberger, R; Grander, W; Tilg, H | 1 |
| Gerbes, AL; Gülberg, V; Neuhofer, W | 1 |
| Barth, F; Dufour, JF; Gerber, PJ; Nicod, LP; Reichen, J | 1 |
| Boyer, L; Chabot, F; Gomez, E; Herve, P; Kheir, A; Le Pavec, J; Sitbon, O | 1 |
| Ashfaq, M; Ausloos, K; Chinnakotla, S; Davis, GL; Klintmalm, GB; Ramsay, M; Rogers, L; Saadeh, S | 1 |
| Halank, M; Hoeffken, G; Hoeper, MM; Pletz, MW; Seyfarth, HJ; Spiekerkoetter, E; Welte, T; Wirtz, H | 1 |
| Kawut, SM | 1 |
| Austin, MJ; Callender, ME; Heneghan, MA; Knisely, AS; McDougall, NI; O'Grady, JG; Rela, M; Sizer, E; Wendon, JA; Wilson, C | 1 |
| Burman, HP; Cahill, PA; O'Donnell, CP; Robotham, JL; Yamamoto, S | 1 |
| Cailmail, S; Calmus, Y; Clozel, M; Gadano, A; Gomola, A; Lebrec, D; Moreau, R; Sogni, P | 1 |
| Hashizume, M; Migoh, S; Sugimachi, K; Tanoue, K; Tsugawa, K | 1 |
Reviews
4 review(s) available for bosentan anhydrous and Cruveilhier-Baumgarten Syndrome
| Article | Year |
|---|---|
Hepatotoxicity by bosentan in a patient with portopulmonary hypertension: a case-report and review of the literature.
Topics: Adult; Antihypertensive Agents; Bosentan; Chemical and Drug Induced Liver Injury; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Sulfonamides | 2011 |
[Portopulmonary hypertension].
Topics: Administration, Inhalation; Administration, Oral; Antihypertensive Agents; Bosentan; Epoprostenol; Hepatopulmonary Syndrome; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Infusions, Intravenous; Lung; Pulmonary Wedge Pressure; Sulfonamides; Survival Rate; Treatment Outcome; Vascular Resistance; Vasodilator Agents | 2005 |
Endothelin and endothelin receptor antagonism in portopulmonary hypertension.
Topics: Administration, Oral; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Liver Transplantation; Pulmonary Circulation; Sulfonamides; Treatment Outcome | 2006 |
[Porto-pulmonary hypertension].
Topics: Antihypertensive Agents; Bosentan; Cardiac Catheterization; Drug Therapy, Combination; Echocardiography; Epoprostenol; Humans; Hypertension, Portal; Hypertension, Pulmonary; Oxygen Inhalation Therapy; Piperazines; Prognosis; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Vasodilator Agents | 2006 |
Other Studies
27 other study(ies) available for bosentan anhydrous and Cruveilhier-Baumgarten Syndrome
| Article | Year |
|---|---|
Treatment with a combination of bosentan and sildenafil allows for successful liver transplantation in a patient with portopulmonary hypertension.
Topics: Adult; Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Transplantation; Male; Piperazines; Purines; Sildenafil Citrate; Sulfonamides; Vasodilator Agents | 2014 |
Secure Combination Therapy With Low-Dose Bosentan and Ambrisentan to Treat Portopulmonary Hypertension Minimizing Each Adverse Effect.
Topics: Antihypertensive Agents; Bosentan; Combined Modality Therapy; Diagnosis, Differential; Dose-Response Relationship, Drug; Echocardiography; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Male; Middle Aged; Phenylpropionates; Pyridazines; Sulfonamides; Treatment Outcome | 2015 |
Endothelin receptor blockers reduce shunting and angiogenesis in cirrhotic rats.
Topics: Animals; Bosentan; Collateral Circulation; Cyclooxygenase 2; Disease Models, Animal; Endothelin A Receptor Antagonists; Endothelin Receptor Antagonists; Hypertension, Portal; Liver Cirrhosis; Male; Neovascularization, Pathologic; Nitric Oxide Synthase Type II; Phenylpropionates; Phosphoproteins; Portal Pressure; Proto-Oncogene Proteins c-akt; Pyridazines; Random Allocation; Rats; Rats, Sprague-Dawley; RNA, Messenger; Sulfonamides; Vascular Endothelial Growth Factor A; Vascular Endothelial Growth Factor Receptor-2 | 2016 |
Portopulmonary hypertension.
Topics: Antihypertensive Agents; Bosentan; Cardiac Catheterization; Echocardiography; Epoprostenol; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Liver Transplantation; Piperazines; Prognosis; Purines; Sildenafil Citrate; Sulfonamides; Sulfones; Vasodilator Agents | 2009 |
Portopulmonary hypertension associated with congenital absence of the portal vein treated with bosentan.
Topics: Antihypertensive Agents; Bosentan; Child; Humans; Hypertension, Portal; Hypertension, Pulmonary; Male; Portal Vein; Sulfonamides; Treatment Outcome | 2009 |
Portopulmonary hypertension: imatinib as a novel treatment and the Emory experience with this condition.
Topics: Antihypertensive Agents; Benzamides; Bosentan; Epoprostenol; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Imatinib Mesylate; Liver Failure; Liver Transplantation; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Sulfonamides; Treatment Outcome | 2009 |
Acute effects of endothelin receptor antagonists on hepatic hemodynamics of cirrhotic and noncirrhotic rats.
Topics: Animals; Antihypertensive Agents; Blood Pressure; Bosentan; Disease Models, Animal; Endothelin Receptor Antagonists; Endothelin-1; Gene Expression; Hemodynamics; Hepatic Stellate Cells; Hypertension, Portal; Liver; Liver Cirrhosis; Male; Oligopeptides; Peptides, Cyclic; Piperidines; Portal Pressure; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Regional Blood Flow; Sulfonamides | 2010 |
Prevalence of spontaneous portosystemic shunts in patients with portopulmonary hypertension and effect on treatment.
Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Case-Control Studies; Child; Drug Therapy, Combination; Epoprostenol; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Magnetic Resonance Imaging; Male; Mesentery; Middle Aged; Piperazines; Purines; Regional Blood Flow; Renal Veins; Retrospective Studies; Severity of Illness Index; Sildenafil Citrate; Splenic Vein; Sulfonamides; Sulfones; Tomography, Spiral Computed; Treatment Outcome; Vena Cava, Inferior | 2011 |
Efficacy and safety of bosentan treatment for portopulmonary hypertension associated with syncope.
Topics: Adult; Antihypertensive Agents; Bosentan; Dose-Response Relationship, Drug; Follow-Up Studies; Humans; Hypertension, Portal; Hypertension, Pulmonary; Male; Monitoring, Physiologic; Pulmonary Wedge Pressure; Sulfonamides; Syncope | 2011 |
Oral vasodilator therapy in patients with moderate to severe portopulmonary hypertension as a bridge to liver transplantation.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Combined Modality Therapy; Exercise Test; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Transplantation; Male; Middle Aged; Phenylpropionates; Phosphodiesterase 5 Inhibitors; Pyridazines; Sulfonamides; Vasodilator Agents | 2013 |
Use of oral endothelin-receptor antagonist bosentan in the treatment of portopulmonary hypertension.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Humans; Hypertension, Portal; Hypertension, Pulmonary; Male; Sulfonamides | 2004 |
Successful treatment of severe portopulmonary hypertension after liver transplantation by bosentan.
Topics: Antihypertensive Agents; Bosentan; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Transplantation; Middle Aged; Sulfonamides; Treatment Outcome | 2004 |
Successful switch from inhalative iloprost to oral bosentan in portopulmonary hypertension associated with liver cirrhosis.
Topics: Administration, Inhalation; Administration, Oral; Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Female; Follow-Up Studies; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Liver Cirrhosis; Liver Transplantation; Middle Aged; Platelet Aggregation Inhibitors; Sulfonamides; Time Factors | 2004 |
Endothelin-receptor antagonist treatment of portopulmonary hypertension.
Topics: Antihypertensive Agents; Bosentan; Female; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Middle Aged; Sulfonamides | 2004 |
Use of a mixed endothelin receptor antagonist in portopulmonary hypertension: a safe and effective therapy?
Topics: Adult; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis, Alcoholic; Male; Sulfonamides; Treatment Outcome | 2005 |
Bosentan therapy for portopulmonary hypertension.
Topics: Adult; Aged; Antihypertensive Agents; Bosentan; Exercise Tolerance; Female; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis, Alcoholic; Male; Middle Aged; Oxygen Consumption; Retrospective Studies; Sulfonamides; Treatment Outcome | 2005 |
Combination therapy for portopulmonary hypertension with intravenous iloprost and oral bosentan.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Drug Therapy, Combination; Follow-Up Studies; Heart Failure; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Injections, Intravenous; Liver Cirrhosis, Alcoholic; Male; Recurrence; Sulfonamides; Time Factors | 2005 |
Successful treatment of portopulmonary hypertension with bosentan: case report.
Topics: Administration, Oral; Adult; Antihypertensive Agents; Bosentan; Echocardiography; Endothelin Receptor Antagonists; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis, Alcoholic; Male; Sulfonamides; Treatment Outcome; Vasodilation | 2006 |
Bosentan treatment of portopulmonary hypertension related to liver cirrhosis owing to hepatitis C.
Topics: Administration, Oral; Aged; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Hepatitis C, Chronic; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Male; Sulfonamides; Treatment Outcome | 2006 |
Efficiency and safety of bosentan in child C cirrhosis with portopulmonary hypertension and renal insufficiency.
Topics: Adult; Antihypertensive Agents; Bosentan; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Male; Renal Insufficiency; Sulfonamides; Treatment Outcome | 2006 |
The impact of treatment of portopulmonary hypertension on survival following liver transplantation.
Topics: Adult; Antihypertensive Agents; Blood Pressure; Bosentan; Diltiazem; Epoprostenol; Female; Humans; Hypertension, Portal; Hypertension, Pulmonary; Liver Cirrhosis; Liver Transplantation; Male; Middle Aged; Retrospective Studies; Sulfonamides; Survival Rate; Treatment Outcome; Vasodilator Agents | 2007 |
Experience with inhaled iloprost and bosentan in portopulmonary hypertension.
Topics: Administration, Inhalation; Adult; Antihypertensive Agents; Bosentan; Catheterization; Disease-Free Survival; Female; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Male; Platelet Aggregation Inhibitors; Proportional Hazards Models; Sulfonamides; Treatment Outcome | 2007 |
Caring for the orphan's orphan: treatment of patients with portopulmonary hypertension.
Topics: Bosentan; Hemodynamics; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Patient Care; Sulfonamides; Survival Analysis | 2007 |
Safety and efficacy of combined use of sildenafil, bosentan, and iloprost before and after liver transplantation in severe portopulmonary hypertension.
Topics: Adult; Blood Pressure; Bosentan; Dose-Response Relationship, Drug; Drug Therapy, Combination; Drug-Related Side Effects and Adverse Reactions; Humans; Hypertension, Portal; Hypertension, Pulmonary; Iloprost; Liver Diseases; Liver Transplantation; Male; Piperazines; Pulmonary Artery; Purines; Severity of Illness Index; Sildenafil Citrate; Sulfonamides; Sulfones; Treatment Outcome; Vasodilator Agents | 2008 |
Endothelin causes portal and pulmonary hypertension in porcine endotoxemic shock.
Topics: Analysis of Variance; Animals; Bosentan; Cyclooxygenase Inhibitors; Endothelin Receptor Antagonists; Endothelin-1; Endothelins; Endotoxemia; Hemodynamics; Hypertension, Portal; Hypertension, Pulmonary; Indomethacin; Liver Circulation; Portal System; Pulmonary Artery; Pulmonary Circulation; Regional Blood Flow; Shock, Septic; Sulfonamides; Swine; Thromboxane B2; Vascular Resistance | 1997 |
Beneficial hemodynamic effects of bosentan, a mixed ET(A) and ET(B) receptor antagonist, in portal hypertensive rats.
Topics: Animals; Antihypertensive Agents; Bosentan; Endothelin Receptor Antagonists; Endothelin-1; Hemodynamics; Hypertension, Portal; Liver Cirrhosis, Experimental; Male; Rats; Rats, Sprague-Dawley; Receptor, Endothelin A; Receptor, Endothelin B; Sulfonamides | 1998 |
Role of endothelin-1 in congestive gastropathy in portal hypertensive rats.
Topics: Animals; Bosentan; Capillary Permeability; Endothelin Receptor Antagonists; Endothelin-1; Enzyme Inhibitors; Gastric Mucosa; Hypertension, Portal; Male; NG-Nitroarginine Methyl Ester; Nitric Oxide; Rats; Rats, Sprague-Dawley; Stomach Diseases; Sulfonamides | 2000 |